Therefore, phenotypical correlations in Gal-9 and Lamp2 deficiency with respect to IBD, pancreatitis, and EIMs might support Gal-9-Lamp2 axis as a potential therapeutic target for these disorders and therefore is worth further investigation in animal models or human subjects. This evidence concerns the gene LAMP2 and inflammatory bowel disease.